Bellerophon Therapeutics Price History

BLPHDelisted Stock  USD 0.71  0.01  1.43%   
If you're considering investing in Bellerophon Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Bellerophon Therapeutics stands at 0.71, as last reported on the 1st of February, with the highest price reaching 0.72 and the lowest price hitting 0.70 during the day. We have found twenty-three technical indicators for Bellerophon Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Bellerophon Therapeutics' Risk Adjusted Performance of (0.14), mean deviation of 5.45, and Standard Deviation of 12.01 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Bellerophon Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
BLPH
Based on monthly moving average Bellerophon Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bellerophon Therapeutics by adding Bellerophon Therapeutics to a well-diversified portfolio.

Bellerophon Therapeutics Pink Sheet Price History Chart

There are several ways to analyze Bellerophon Stock price data. The simplest method is using a basic Bellerophon candlestick price chart, which shows Bellerophon Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Bellerophon Pink Sheet Price History Data

The price series of Bellerophon Therapeutics for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 9.9 with a coefficient of variation of 88.46. The prices are distributed with arithmetic mean of 4.41. The median price for the last 90 days is 0.94. The company had 1:15 stock split on 10th of February 2020. Bellerophon Therapeutics issued dividends on 2020-02-10.
OpenHighLowCloseVolume
02/01/2025
 0.70  0.72  0.70  0.71 
07/24/2023 0.70  0.72  0.70  0.71  48,032 
07/21/2023 0.73  0.73  0.70  0.70  180,034 
07/20/2023 0.75  0.75  0.70  0.72  107,730 
07/19/2023 0.76  0.76  0.72  0.73  93,762 
07/18/2023 0.75  0.76  0.74  0.75  180,951 
07/17/2023 0.74  0.75  0.73  0.75  83,818 
07/14/2023 0.75  0.75  0.73  0.75  136,245 
07/13/2023 0.72  0.76  0.72  0.76  412,762 
07/12/2023 0.71  0.74  0.69  0.73  512,421 
07/11/2023 0.69  0.71  0.68  0.69  125,200 
07/10/2023 0.68  0.69  0.67  0.67  94,738 
07/07/2023 0.68  0.70  0.65  0.70  254,991 
07/06/2023 0.68  0.69  0.68  0.69  119,500 
07/05/2023 0.70  0.71  0.67  0.70  388,900 
07/03/2023 0.68  0.68  0.67  0.67  131,852 
06/30/2023 0.68  0.70  0.65  0.69  509,175 
06/29/2023 0.70  0.70  0.66  0.68  291,215 
06/28/2023 0.74  0.74  0.69  0.70  214,200 
06/27/2023 0.70  0.74  0.67  0.74  381,874 
06/26/2023 0.71  0.71  0.67  0.71  389,261 
06/23/2023 0.70  0.71  0.69  0.71  214,545 
06/22/2023 0.70  0.70  0.68  0.70  167,137 
06/21/2023 0.72  0.72  0.68  0.71  298,001 
06/20/2023 0.71  0.71  0.69  0.69  331,200 
06/16/2023 0.71  0.72  0.68  0.68  441,663 
06/15/2023 0.72  0.72  0.69  0.71  614,800 
06/14/2023 0.72  0.74  0.70  0.71  435,100 
06/13/2023 0.72  0.75  0.69  0.72  875,069 
06/12/2023 0.72  0.75  0.69  0.70  905,400 
06/09/2023 0.77  0.77  0.72  0.72  1,221,599 
06/08/2023 0.80  0.80  0.76  0.77  1,421,500 
06/07/2023 0.88  0.90  0.79  0.83  2,245,645 
06/06/2023 0.92  1.04  0.88  0.90  3,359,849 
06/05/2023 1.30  1.34  0.89  0.94  12,747,759 
06/02/2023 6.87  7.09  6.87  7.06  18,864 
06/01/2023 6.91  6.91  6.66  6.89  19,284 
05/31/2023 7.00  7.04  6.83  6.91  19,188 
05/30/2023 7.50  7.51  6.88  7.06  73,754 
05/26/2023 6.94  7.49  6.81  7.44  62,500 
05/25/2023 7.48  7.49  6.69  6.83  99,215 
05/24/2023 7.57  7.86  7.28  7.48  129,017 
05/23/2023 7.47  7.57  6.60  7.57  191,138 
05/22/2023 7.92  8.30  7.47  7.52  95,800 
05/19/2023 9.36  9.46  7.56  7.92  251,701 
05/18/2023 10.62  10.62  9.46  9.46  124,468 
05/17/2023 10.78  11.15  10.39  10.57  109,866 
05/16/2023 8.99  10.88  8.90  10.39  330,422 
05/15/2023 8.88  9.00  8.62  8.71  82,293 
05/12/2023 8.81  8.93  8.56  8.77  97,600 
05/11/2023 8.98  9.00  8.50  8.84  95,400 
05/10/2023 8.75  8.87  8.57  8.63  80,290 
05/09/2023 8.82  9.08  8.51  8.80  79,312 
05/08/2023 9.17  9.17  8.47  8.49  56,965 
05/05/2023 9.36  9.81  8.93  9.07  77,846 
05/04/2023 8.57  9.74  8.51  9.30  63,224 
05/03/2023 7.74  8.85  7.74  8.64  100,783 
05/02/2023 7.95  8.00  7.70  7.75  32,600 
05/01/2023 7.42  7.99  7.19  7.83  77,600 
04/28/2023 7.27  7.83  7.27  7.65  62,152 
04/27/2023 7.07  7.63  7.07  7.57  51,184 

About Bellerophon Therapeutics Pink Sheet history

Bellerophon Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bellerophon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bellerophon Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bellerophon Therapeutics stock prices may prove useful in developing a viable investing in Bellerophon Therapeutics
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Bellerophon Ther operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.

Bellerophon Therapeutics Pink Sheet Technical Analysis

Bellerophon Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Bellerophon Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bellerophon Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
All  Next Launch Module

Bellerophon Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bellerophon Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Bellerophon Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bellerophon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Bellerophon Pink Sheet

If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital